Curis Inc (CRIS)
16.36
-0.15
(-0.91%)
USD |
NASDAQ |
May 03, 16:00
16.70
+0.34
(+2.08%)
After-Hours: 20:00
Curis Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.0073 |
December 31, 2020 | 0.0068 |
September 30, 2020 | -0.0311 |
June 30, 2020 | -0.0293 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | -7.892 |
September 30, 2018 | 47.50 |
June 30, 2018 | 5.414 |
March 31, 2018 | 2.748 |
December 31, 2017 | 1.732 |
Date | Value |
---|---|
September 30, 2017 | 1.408 |
June 30, 2017 | 4.756 |
March 31, 2017 | 2.086 |
December 31, 2016 | 0.6786 |
September 30, 2016 | 0.5519 |
June 30, 2016 | 0.4756 |
March 31, 2016 | 0.4094 |
December 31, 2015 | 0.3746 |
September 30, 2015 | 0.3359 |
June 30, 2015 | 0.3306 |
March 31, 2015 | 0.3125 |
December 31, 2014 | 0.9502 |
September 30, 2014 | 0.8388 |
June 30, 2014 | 0.7579 |
March 31, 2014 | 0.7454 |
December 31, 2013 | 0.6764 |
September 30, 2013 | 0.7356 |
June 30, 2013 | 0.928 |
March 31, 2013 | 0.9963 |
December 31, 2012 | 0.8708 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0311
Minimum
Sep 2020
0.0073
Maximum
Mar 2021
-0.0024
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
AIM ImmunoTech Inc | 0.00 |
Perspective Therapeutics Inc | 0.0229 |
Protalix BioTherapeutics Inc | 0.6033 |
Electromed Inc | 0.00 |
Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 77.28M |
Total Liabilities (Quarterly) | 57.61M |
Shareholders Equity (Quarterly) | 19.67M |
Current Ratio | 4.506 |